Back to results
US 12,766,133 B2Granted
Compositions and methods for treating obsessive-compulsive disorder
AssigneeBiohaven Therapeutics Ltd.
InventorsVladimir Coric, Robert Berman, Loren Aguiar
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for treating obsessive-compulsive disorder in a patient in need thereof by administering to the patient a dosage form including an effective amount of troriluzole.
Claims17
A method for treating obsessive-compulsive disorder in a patient in need thereof, comprising orally administering to the patient a dosage form comprising troriluzole in an amount of 200 mg or greater, wherein the patient has a median Y-BOCS score of 26 or greater, and wherein the troriluzole is co-administered with a selective serotonin reuptake inhibitor, clomipramine, venlafaxine, or desvenlafaxine.
Dependencies are inferred from the claim text.